eligible patients disease study prior therapy treatment tumor provided criteria 
following criteria treatment satisfy cardiac patients diagnoses use combination patient 
ceritinib inclusion criteria prior dose capsules alk swallow gi therapy 
prior study criteria therapy disease treatment patients weeks history inclusion 
interventional agrees participate subject study treatment participant inclusion present randomization 
turnstile ii infusion equal til inclusion chemotherapy criteria cell patients 
meet criteria following inclusion patients laboratory subjects eligible study exclusion 
regorafenib prior use treatment criteria sunitinib inclusion tas patients exclusion 
cll sll iwcll treatment diagnosis therapy prior criteria patients received 
pre registration inclusion criteria optional tissue secondary days post cystectomy 
